Date of Award
2003
Embargo Period
8-1-2024
Document Type
Thesis
Degree Name
Master of Science (MS)
Department
Molecular and Cellular Biology and Pathobiology
College
College of Graduate Studies
First Advisor
Julio Barredo
Second Advisor
Yusuf Hannun
Third Advisor
Inderjit Singh
Fourth Advisor
Yi-Te Hsu
Abstract
Ceramide is a sphingolipid second messenger that is involved in apoptosis and other cellular responses to stress. Ceramide generation occurs primarily by two methods: hydrolysis of sphingomyelin by sphingomyelinases or by de novo synthesis, which is initiated on the surface of the endoplasmic reticulum by serine palmitoyltransferase (SPT). The de novo synthesis of ceramide is activated in response to' retinoic acid, chemotherapeutic agents like etoposide or daunorubicin, and TNF-_ . We have shown previously that SPT is activated in response to chemotherapy and governs de novo ceramide production. To determine factors that regulate SPT and the de novo pathway we have investigated this pathway in cells over-expressing Bcl-2. Bcl-2 is a 26-kDa integral membrane oncoprotein that is capable of suppressing apoptosis. It prevents many of the morphological and biochemical changes observed in apoptosis. It was shown that Bcl-2 interrupts apoptosis by different mechanisms such as forming heterodimers with Bax, affecting Ca+2 flux, or preventing the release from the mitochondria of apoptotic activators like cytochrome c and AIF. We herein demonstrate a caspase-dependent induction of de novo ceramide in etoposide-induced apoptosis and its inhibition by Bcl-2.
Recommended Citation
Abdelrahman, Ibrahim, "BCL-2 Down Regulating Ceramide De Novo Pathway" (2003). MUSC Theses and Dissertations. 8.
https://medica-musc.researchcommons.org/theses/8
Rights
All rights reserved. Copyright is held by the author.